By vgreene, 2 March, 2020 Counsel pts on how to safely d/c and restart PrEP both when starting PrEP and when d/c’ing PrEP as HIV infxn protection wanes 7-10 days after ceasing daily PrEP use
By vgreene, 2 March, 2020 Goal: informed decision based on what is known/unknown about benefits/risks of PrEP for mother/fetus [IIB]
By vgreene, 2 March, 2020 Serodiscordant heterosexual couples at time of conception/pregnancy; includes transgender persons: Consider use of PrEP for all those at risk of acquiring HIV sexually5
By vgreene, 2 March, 2020 Adult heterosexually active men & women; includes transgender persons: Consider use of PrEP for all those at risk of acquiring HIV sexually5
By vgreene, 2 March, 2020 Counsel pts on how to safely d/c and restart PrEP both when starting PrEP and when d/c’ing PrEP as HIV infxn protection wanes 7-10 days after ceasing daily PrEP use
By vgreene, 2 March, 2020 Consider HCV testing as part of baseline lab eval; but if born btwn 1945 through 1965 AND never before tested for HCV, test for HCV (even w/o prior ascertainment for HCV risk factors); consider annual retesting for those w/ ongoing risk of HCV exposure
By vgreene, 2 March, 2020 F/U q3mo for HIV test [IA],2 preg test, med adherence counseling, risk redux support [IIIA], ADR & STI assessment; test for bacterial STIs (gonorrhea, chlamydia, syphilis) q3-6mo